Chauhan, R., Saxena, N., Kapur, N
This therapy is designed to replenish NAD levels, which typically decline with age and can lead to various signs of aging and neurodegenerative diseases
Crucially, weight loss showed no plateau effect in either the Phase 2 or Phase 3 studies, a characteristic that has drawn comparisons with the most effective agents currently on the market
When used in combination, CJC-1295 and Ipamorelin provide a more robust stimulation of GH secretion than either peptide alone. Khorram & Mulligan, Endocrine Reviews Half-Life and Dosing CJC-1295 (with DAC) : Half-life ~68 days Ipamorelin : Half-life ~2 hours Recommended stack : CJC-1295 (2 mg, 12x/week) + Ipamorelin (100300 mcg, 12x/day) Key Differences Summary: How They Work Together CJC-1295 and Ipamorelin work together by mimicking and enhancing the bodys natural growth hormone (GH) rhythm
Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of alzheimers disease
Pharmacokinetic Profile Fernandez-Perez et al